Oxygen consumption type inorganic nano-enzyme treatment reagent as well as preparation method and application thereof
A therapeutic reagent and inorganic nanotechnology, applied in nanotechnology, nanotechnology, nanomedicine, etc., can solve the problems of unrealizable process simplification and large-scale preparation, achieve precise and specific tumor treatment, prevent recurrence and metastasis, well-structured effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] Synthesis of AQ4N@Cu-Ag NPs
[0050] Step (1), add silver nitrate solution (1mL, 0.2M), copper nitrate solution (1mL, 0.1M) and polyvinylpyrrolidone K15 solution (100mL, 5g / L) into a 500mL beaker, stir at room temperature for 30min and mix well to obtain Mixed solution, add the hydrazine hydrate mixed solution containing L-ascorbic acid and sodium hydroxide to the mixed solution (consisting of 100mL concentration of 50mM L-ascorbic acid aqueous solution, 100mL concentration of 5g / L sodium hydroxide aqueous solution and 30μL concentration of 35wt% Mixed with hydrazine hydrate), reacted at room temperature for 10 min, centrifuged, washed three times with absolute ethanol, and dried to obtain copper-silver alloy nanoparticles (Cu-AgNPs), which were brown-gray solid powder; SEM image of Cu-Ag NPs and transmission electron microscope images, see figure 1 and figure 2 , indicating that the Cu-Ag NPs exhibit a porous spherical shape, and the size of the synthesized Cu-Ag NP...
Embodiment 2
[0054] Cu-Ag NPs consume O 2 performance
[0055] A portable dissolved oxygen meter was used to test the ability of nanoparticles to catalyze oxygen consumption under different conditions. The test was divided into 5 groups: the first group was the blank control group, which was 10 mL of deionized water; the second group was the Cytc control group, which was 10 mL of the Cytc solution ( The concentration was 10 μg / mL, prepared with deionized water, and the pH value was 6.75); the third group was the Cu-Ag NPs control group, which was 10 mL of Cu-Ag NPs dispersion (concentration of 100 μg / mL, prepared with deionized water, The pH value is 6.75); the fourth group is the Cu-Ag+Cytc control group, 10 μL Cytc (10 mg / mL) was added to 10 mL Cu-Ag NPs dispersion (concentration 100 μg / mL, prepared with deionized water, pH value was 7.35, simulating the neutral environment of normal tissue); the fifth group was the Cu-Ag+Cytc group, 10 μL Cytc (10 mg / mL) was added to 10 mL Cu-Ag NPs di...
Embodiment 3
[0069] Apoptosis test of AQ4N@Cu-Ag NPs
[0070] In order to explore the apoptosis mechanism of AQ4N@Cu-Ag NPs, 4T1 breast cancer cells were tested by flow cytometry. @Cu-AgNPs dispersion, Cu-Ag NPs dispersion with a concentration of 100 μg / mL, and AQ4N solution with a concentration of 100 μg / mL; 4T1 breast cancer cells were grown in a hexagonal medium containing 2 mL of 1640 medium at 37 °C with 5% carbon dioxide. After incubation in the well plate for 24 hours, 4T1 breast cancer cells were treated differently: i) blank control group (Control): 100 μL of pH 7.4 phosphate buffer was added; ii) the first treatment group (AQ4N): 100 μL of 100 μg / mL AQ4N solution; iii) the second treatment group (Cu-AgNPs): add 100 μL 100 μg / mL Cu-Ag NPs dispersion; iv) the third treatment group (AQ4N@Cu-Ag NPs): add 100 μL 100 μg / mL AQ4N @Cu-Ag NPs dispersion. The 4T1 breast cancer cells were further incubated at 37°C with 5% carbon dioxide for 24 hours, and the dead cells were stained with pr...
PUM
Property | Measurement | Unit |
---|---|---|
concentration | aaaaa | aaaaa |
concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information

- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com